mucocutaneous lymph node syndrome: Kawasaki disease (KD) is a febrile, systemic, self-limiting vasculitis affecting children and characterized by inflammation in the medium sized vessels associated with coronary arterial aneurysms (CAA) that may be life threatening when untreated. KD is the most common cause of acquired heart disease in children in developed countries and is a risk factor for ischemic heart disease in adulthood.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
81 |
4. Check minimum number of eventsNone |
81 |
5. Include endpointsNone |
81 |
6. Filter based on genotype QC (FinnGen only) |
81 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30
- Name in latin
- Syndroma mucocutaneum lymphonodorum (Kawasaki)
Similar endpoints
↥List of similar endpoints to
Mucocutaneous lymph node syndrome [Kawasaki]
based on the number of shared cases.
Similar with more cases:
- Polyarteritis nodosa and related conditions
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1816 | 687 | 1129 |
| Only index persons | 1386 | 500 | 886 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.02 | 0.03 |
| Only index persons | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | - | 4.24 | 3.84 |
| Only index persons | 4.78 | 5.46 | 4.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 81 | 43 | 38 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 7.47 | 6.38 | 8.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 74
- Matched controls
- 738
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M30.3
ICD-10 Finland
Mucocutaneous lymph node syndrome [Kawasaki]
+∞
61.1
50
*
4461A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Acute febrile mucocutaneous lymph node syndrome [MCLS]
+∞
31.5
28
*
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
10.7
10
*
L04AX01
ATC
azathioprine; systemic
15.9
7.1
11
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
25
116
2.67
3.72
3.0
3.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
38
245
2.04
2.49
10.1
10.8
mmol/l
1.2
1.2
0.42
33
216
(3030467) Casts [#/volume] in Urine by Automated count
28
166
2.05
2.27
2.8
3.5
e6/l
0.3
0.4
0.03
22
127
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
37
2.94
2.19
2.8
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
28
169
2.00
2.15
2.9
3.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
50
2.64
2.14
2.2
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
10
5.25
2.10
1.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
16
3.96
1.97
1.2
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
11
4.76
1.97
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
28
174
1.93
1.96
8.0
5.8
inr
1.1
1.2
—
10
51
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
29
2.95
1.85
1.6
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
30
198
1.82
1.72
3.3
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
25
156
1.87
1.70
2.6
2.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
29
190
1.82
1.70
2.8
3.4
e6/l
8.9
370.3
0.57
23
151
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
31
208
1.79
1.68
2.8
3.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
14
3.73
1.64
3.2
4.5
%
54.6
53.9
—
5
14
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
14
3.73
1.64
3.2
4.4
e9/l
3.5
3.4
—
5
14
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
12
58
2.25
1.58
6.2
5.6
mmol/l
24.8
23.5
1.40
12
58
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
43
0.00
1.57
0.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
175
0.45
1.53
1.6
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
43
329
1.65
1.40
3.1
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
42
2.28
1.39
1.6
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
18
2.89
1.30
2.8
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
28
195
1.67
1.29
9.5
6.7
g/l
34.6
37.4
1.20
28
189
(3022217) INR in Platelet poor plasma by Coagulation assay
0
33
0.00
1.19
0.0
17.0
—
1.1
—
0
9
(3029937) Albumin [Presence] in Urine by Test strip
23
155
1.68
1.18
3.0
3.4
estimate
0.0
0.0
0.00
13
54
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
66
1.96
1.16
8.0
8.5
mmol/l
25.4
25.0
0.26
12
66
(3000991) Gas panel - Venous blood
13
74
1.90
1.15
5.8
10.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
41
322
1.55
1.12
8.9
6.9
e9/l
0.0
0.0
0.50
36
258
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
140
1.68
1.12
5.3
2.7
ng/l
59.9
25.2
—
9
66
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
32
2.30
1.11
1.0
1.0
—
—
—
0
0
(3012544) pH of Venous blood
13
77
1.82
1.02
5.8
6.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
30
0.00
0.99
0.0
2.1
—
10.9
—
0
24
(42870588) Differential panel, method unspecified - Blood
31
234
1.53
0.99
8.9
6.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
36
282
1.50
0.96
3.3
2.9
ug/l
156.6
72.5
0.84
36
266
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
27
2.32
0.95
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
88
1.71
0.91
1.1
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
88
1.71
0.91
1.1
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
88
1.71
0.91
1.1
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
29
2.15
0.91
1.2
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
18
122
1.61
0.90
5.2
5.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
30
229
1.49
0.90
3.0
3.8
e6/l
35.6
45.5
0.14
23
156
(3022313) Gas panel - Capillary blood
12
74
1.73
0.83
7.2
4.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
33
1.88
0.81
1.3
4.2
%
99.3
86.4
—
6
33
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
17
117
1.57
0.80
1.6
2.3
mg/l
1.7
0.7
0.86
11
86
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
152
0.61
0.70
4.0
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
87
1.59
0.68
1.2
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
5
28
1.84
0.67
6.2
6.0
g/l
0.3
0.2
—
5
17
(3042936) Bacteria identified in Isolate by Culture
10
63
1.67
0.65
4.2
2.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
12
81
1.57
0.61
8.6
5.1
kpa
5.0
5.1
0.16
12
76
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
12
81
1.57
0.61
8.6
5.0
mmol/l
1.8
1.3
0.57
12
54
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
52
461
1.36
0.60
3.1
3.7
pmol/l
14.7
14.6
0.09
47
414
(3011397) Hemoglobin [Presence] in Urine by Test strip
10
146
0.64
0.59
3.0
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
162
1.40
0.58
1.5
1.8
pmol/l
98.0
95.8
0.06
11
79
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
38
1.62
0.55
3.8
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
84
1.50
0.53
1.2
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
65
602
1.40
0.52
18.7
13.5
%
13.3
13.3
0.08
65
591
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
139
1.38
0.49
2.0
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
128
0.67
0.48
1.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
34
292
1.28
0.46
3.7
4.5
estimate
0.0
0.0
0.00
13
58
(3035350) Ketones [Presence] in Urine by Test strip
34
292
1.28
0.46
2.9
3.2
estimate
0.0
0.0
0.00
13
55
(40761536) Microorganisms panel - Urine sediment
8
55
1.50
0.45
2.9
3.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
70
1.49
0.44
1.1
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
32.6
—
0
18
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
30
258
1.26
0.39
5.1
6.1
umol/l
21.9
12.1
0.42
30
243
(3020682) Albumin/Creatinine [Ratio] in Urine
14
108
1.36
0.38
4.9
3.8
mg/mmol
65.2
21.5
—
8
73
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
70
1.32
0.38
2.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
48
437
1.24
0.37
5.5
4.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
21
249
0.79
0.36
1.5
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
17
138
1.29
0.34
1.9
2.3
mg/l
2.4
2.4
0.01
17
124
(3000492) Spirometry study
7
51
1.41
0.32
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
7
56
1.27
0.30
1.1
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
70
671
1.32
0.30
15.4
9.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
64
608
1.25
0.29
3.7
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
16
191
0.80
0.28
3.8
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
73
1.26
0.26
3.4
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
33
297
1.19
0.26
3.0
3.3
estimate
0.0
0.0
0.00
13
55
(3026008) Bacteria identified in Urine by Culture
15
179
0.80
0.26
3.5
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
231
0.82
0.26
2.3
1.7
—
—
—
0
0
(3013512) EKG study
12
96
1.29
0.26
4.9
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
21
181
1.22
0.26
6.5
6.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
76
1.21
0.26
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
8
104
0.74
0.22
10.6
9.4
mmol/l
1.1
1.2
—
8
99
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
112
0.78
0.21
1.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4034850)
0
11
0.00
0.21
0.0
19.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(4306422)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
68
656
1.23
0.21
10.6
8.1
u/l
31.6
26.5
0.52
68
626
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
26
288
0.86
0.21
6.1
4.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
47
1.30
0.21
1.0
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
13
0.00
0.21
0.0
1.4
—
281.5
—
0
13
(3002523) Influenza virus A Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.2
—
377.3
—
0
13
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
12
100
1.23
0.19
2.3
3.1
e6/l
0.1
0.3
—
7
55
(40768797) Stomach Pathology biopsy report
7
57
1.25
0.19
1.9
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
61
1.16
0.18
1.3
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
5
65
0.75
0.17
1.4
2.7
—
3554.0
—
0
30
(3050129) First trimester maternal screen panel - Serum or Plasma
5
68
0.72
0.17
1.6
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
69
0.71
0.17
3.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
217
1.15
0.17
2.0
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
92
1.23
0.17
1.8
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
71
1.14
0.17
3.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
8
71
1.14
0.17
1.9
1.6
pmol/l
360.5
469.4
—
8
65
(3015736) pH of Urine
26
237
1.14
0.16
2.5
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
75
0.78
0.16
1.7
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
67
651
1.17
0.14
18.3
12.9
%
40.1
40.4
0.22
58
560
(40768804) Tissue Pathology biopsy report
21
190
1.14
0.14
2.2
1.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
63
610
1.15
0.14
18.4
14.7
g/l
334.8
334.5
0.06
63
605
(3007164) IgA [Mass/volume] in Serum or Plasma
17
189
0.87
0.13
1.4
1.6
g/l
2.0
2.0
—
9
106
(3019832) Treponema pallidum Ab [Presence] in Serum
17
187
0.88
0.11
1.5
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
42
439
0.91
0.11
4.0
3.9
mmol/mol
36.8
37.1
0.08
42
411
(3005033) Fetal Nuchal fold Thickness US
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
205
0.90
0.09
2.7
2.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
61
0.81
0.08
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
63
0.78
0.08
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
64
0.77
0.08
1.4
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
98
1.14
0.08
3.3
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
74
1.09
0.08
4.9
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
84
1.08
0.07
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
50
486
1.08
0.07
13.3
8.6
ml/min/173m2
94.2
97.5
0.34
38
369
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
99
1.13
0.07
2.5
3.1
e6/l
0.5
1.5
—
6
55
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
192
0.92
0.06
2.3
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
65
642
1.06
0.02
17.9
10.7
mg/l
28.7
22.6
0.56
55
465
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
122
0.98
0.00
2.3
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
119
1.01
0.00
1.9
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
266
1.02
0.00
2.4
2.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
1.3
—
13.7
—
0
6
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
57
0.87
0.00
1.2
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
57
0.87
0.00
1.2
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
49
1.02
0.00
1.0
1.6
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
4.1
—
0
6
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
57
0.87
0.00
1.2
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
109.2
—
0
6
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
31.2
—
0
9
(3000093) Morphology [Interpretation] in Blood Narrative
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
1.4
—
1.3
—
0
9
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
2.6
—
0.1
—
0
7
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
14.7
—
859.1
—
0
9
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
1.5
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
2.2
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
57
0.87
0.00
1.2
1.5
—
—
—
0
0
(4062490)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(4268621)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.7
—
12.7
—
0
9
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.7
—
2.1
—
0
7
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
8.7
—
0
6
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
26.3
—
1687.6
—
0
9
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
54.1
—
0
8
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
21.4
—
0
5
(3038515) Glucose [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
1.6
—
6.1
—
0
7
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_KAWASAKI and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_KAWASAKI.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_KAWASAKI – Mucocutaneous lymph node syndrome [Kawasaki]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data